Lyka Labs Limited (NSE:LYKALABS)

India · Delayed Price · Currency is INR

56.50

-0.57 (-1.00%)

Mar 10, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	1.35B	1.06B	894.17M	1.84B	685.11M
Pharmaceuticals Growth	27.04%	18.75%	-51.53%	169.25%	20.82%
Total	1.35B	1.06B	894.17M	1.84B	685.11M
Total Growth	27.04%	18.75%	-51.53%	169.25%	20.82%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	847.86M	631.75M	417.30M	1.30B	342.27M
India Growth	34.21%	51.39%	-67.91%	279.95%	-10.27%
Rest of World	487.79M	419.58M	466.09M	535.41M	328.80M
Rest of World Growth	16.26%	-9.98%	-12.95%	62.84%	89.65%
Total	1.34B	1.05B	883.39M	1.84B	671.07M
Total Growth	27.04%	19.01%	-51.88%	173.57%	20.96%

Source: S&P Global Market Intelligence.